{
    "Trade/Device Name(s)": [
        "i-STAT CHEM8+ cartridge with the i-STAT 1 System"
    ],
    "Submitter Information": "Abbott Point of Care Inc.",
    "510(k) Number": "K183680",
    "Predicate Device Reference 510(k) Number(s)": [
        "K163342"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPI"
    ],
    "Summary Letter Date": "January 23, 2020",
    "Summary Letter Received Date": "January 24, 2020",
    "Submission Date": "February 19, 2020",
    "Regulation Number(s)": [
        "21 CFR 864.6400"
    ],
    "Regulation Name(s)": [
        "Hematocrit measuring device"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hematocrit"
    ],
    "Specimen Type(s)": [
        "Arterial whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "i-STAT 1 Analyzer",
        "i-STAT 1 System"
    ],
    "Method(s)/Technology(ies)": [
        "Conductivity method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Cartridge",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for i-STAT CHEM8+ cartridge with the i-STAT 1 System for quantitative hematocrit measurement in arterial or venous whole blood at point of care or in clinical laboratory settings.",
    "Indications for Use Summary": "Intended for in vitro quantification of hematocrit in arterial or venous whole blood in point of care or clinical laboratory settings to aid in determination and monitoring of total red cell volume status associated with conditions including anemia and erythrocytosis; not evaluated in neonates.",
    "fda_folder": "Hematology"
}